Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer

Wu, 2008, Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy, J Natl Med Assoc, 100, 490, 10.1016/S0027-9684(15)31295-5 Louwman, 2005, Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study, Eur J Cancer, 41, 779, 10.1016/j.ejca.2004.12.025 Land, 2012, Comorbidity and survival after early breast cancer. A review, Crit Rev Oncol Hematol, 81, 196, 10.1016/j.critrevonc.2011.03.001 Berglund, 2012, Impact of comorbidity on management and mortality in women diagnosed with breast cancer, Breast Cancer Res Treat, 135, 281, 10.1007/s10549-012-2176-4 Braithwaite, 2009, Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients, Int J Cancer, 124, 1213, 10.1002/ijc.24054 Kimmick, 2014, Comorbidity burden and guideline-concordant care for breast cancer, J Am Geriatr Soc, 62, 482, 10.1111/jgs.12687 Hawfield, 2006, Retrospective study of the effect of comorbidity on use of adjuvant chemotherapy in older women with breast cancer in a tertiary care setting, Crit Rev Oncol Hematol, 59, 250, 10.1016/j.critrevonc.2005.12.004 Lee, 2011, Impact of comorbidity on chemotherapy use and outcomes in solid tumors: a systematic review, J Clin Oncol, 29, 106, 10.1200/JCO.2010.31.3049 German, 2011, Quality of cancer registry data: findings from CDC-NPCR's breast and prostate cancer data quality and patterns of care study, J Registry Manag, 38, 75 Wu, 2012, Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers, J Clin Oncol, 30, 142, 10.1200/JCO.2011.36.8399 Piccirillo, 2003, The measurement of comorbidity by cancer registries, J Registry Manag, 30, 8 Piccirillo, 2006, Prognostic importance of comorbidity in a hospital-based cancer registry, JAMA, 291, 2441, 10.1001/jama.291.20.2441 Johnson, 2001, Validation of a comorbidity education program, J Registry Manag, 28, 125 Houterman, 2004, Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients, Br J Cancer, 90, 2332, 10.1038/sj.bjc.6601844 Sheppard, 2011, Stage at diagnosis and comorbidity influence breast cancer survival in first nations women in Ontario, Canada, Cancer Epidemiol Biomarkers Prev, 20, 2160, 10.1158/1055-9965.EPI-11-0459 Land, 2012, Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008, Breast Cancer Res Treat, 131, 1013, 10.1007/s10549-011-1819-1 Carlsen, 2008, Social inequality and incidence of and survival from breast cancer in a population-based study in Denmark, 1994–2003, Eur J Cancer, 44, 1996, 10.1016/j.ejca.2008.06.027 Cronin-Fenton, 2007, Comorbidity and survival of Danish breast cancer patients from 1995 to 2005, Br J Cancer, 96, 1462, 10.1038/sj.bjc.6603717 Peairs, 2011, Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis, J Clin Oncol, 29, 40, 10.1200/JCO.2009.27.3011 Budman, 1998, Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The cancer and leukemia group B, J Natl Cancer Inst, 90, 1205, 10.1093/jnci/90.16.1205 Henry, 2008, Drug interactions and pharmacogenomics in the treatment of breast cancer and depression, Am J Psychiatry, 165, 1251, 10.1176/appi.ajp.2008.08040482 Fleming, 2011, Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review, Med Care, 49, 752, 10.1097/MLR.0b013e318215d7dd Piccirillo, 1999, Inclusion of comorbidity into oncology data registry, J Registry Manag, 26, 66 Siegelmann-Danieli, 2006, Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach, Clin Breast Cancer, 7, 59, 10.3816/CBC.2006.n.014 Field, 2011, Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer, J Am Coll Surg, 213, 757, 10.1016/j.jamcollsurg.2011.09.010 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 D'Hoore, 1996, Practical considerations on the use of the Charlson comorbidity index with administrative data bases, J Clin Epidemiol, 49, 1429, 10.1016/S0895-4356(96)00271-5 Wedding, 2007, Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale, Crit Rev Oncol Hematol, 61, 269, 10.1016/j.critrevonc.2006.11.001 Gradishar, 2016, Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 14, 324, 10.6004/jnccn.2016.0037 Kimmick, 2011, Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making, Curr Treat Options Oncol, 12, 286, 10.1007/s11864-011-0159-z